|
Name |
Ophiobolin R
|
Molecular Formula | C26H38O4 | |
IUPAC Name* |
(1R,3S,7R,8E,11S,12R)-12-[(2S)-6-hydroxy-5-methoxy-6-methylhept-3-en-2-yl]-1,4-dimethyl-6-oxotricyclo[9.3.0.03,7]tetradeca-4,8-diene-8-carbaldehyde
|
|
SMILES |
CC1=CC(=O)[C@@H]/2[C@@H]1C[C@]3(CC[C@@H]([C@@H]3C/C=C2/C=O)[C@@H](C)C=CC(C(C)(C)O)OC)C
|
|
InChI |
InChI=1S/C26H38O4/c1-16(7-10-23(30-6)25(3,4)29)19-11-12-26(5)14-20-17(2)13-22(28)24(20)18(15-27)8-9-21(19)26/h7-8,10,13,15-16,19-21,23-24,29H,9,11-12,14H2,1-6H3/b10-7?,18-8-/t16-,19+,20+,21-,23?,24-,26+/m0/s1
|
|
InChIKey |
VDDDNUHBNZDCIZ-DJSDRJBNSA-N
|
|
Synonyms |
Ophiobolin R
|
|
CAS | NA | |
PubChem CID | 139588182 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 414.6 | ALogp: | 3.8 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 63.6 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.484 |
Caco-2 Permeability: | -4.582 | MDCK Permeability: | 0.00002040 |
Pgp-inhibitor: | 0.986 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.023 | 20% Bioavailability (F20%): | 0.042 |
30% Bioavailability (F30%): | 0.05 |
Blood-Brain-Barrier Penetration (BBB): | 0.009 | Plasma Protein Binding (PPB): | 93.75% |
Volume Distribution (VD): | 2.084 | Fu: | 5.02% |
CYP1A2-inhibitor: | 0.063 | CYP1A2-substrate: | 0.582 |
CYP2C19-inhibitor: | 0.13 | CYP2C19-substrate: | 0.79 |
CYP2C9-inhibitor: | 0.382 | CYP2C9-substrate: | 0.048 |
CYP2D6-inhibitor: | 0.334 | CYP2D6-substrate: | 0.045 |
CYP3A4-inhibitor: | 0.916 | CYP3A4-substrate: | 0.686 |
Clearance (CL): | 2.103 | Half-life (T1/2): | 0.236 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.033 |
Drug-inuced Liver Injury (DILI): | 0.165 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.191 | Maximum Recommended Daily Dose: | 0.732 |
Skin Sensitization: | 0.194 | Carcinogencity: | 0.291 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.015 |
Respiratory Toxicity: | 0.969 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002981 | 0.828 | D0N1TP | 0.273 | ||||
ENC003687 | 0.708 | D0G8OC | 0.238 | ||||
ENC003251 | 0.685 | D0G5CF | 0.235 | ||||
ENC005803 | 0.566 | D0V2JK | 0.230 | ||||
ENC002982 | 0.564 | D06JPB | 0.229 | ||||
ENC005045 | 0.553 | D06AEO | 0.226 | ||||
ENC005044 | 0.539 | D04GJN | 0.221 | ||||
ENC003783 | 0.481 | D05BTM | 0.216 | ||||
ENC002000 | 0.481 | D0W5LS | 0.216 | ||||
ENC005046 | 0.389 | D02ZGI | 0.216 |